Y-Intercept (HK)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.98M | Buy |
17,315
+13,160
| +317% | +$3.78M | 0.12% | 221 |
|
2025
Q1 | $1.28M | Sell |
4,155
-2,015
| -33% | -$621K | 0.09% | 322 |
|
2024
Q4 | $2.18M | Buy |
+6,170
| New | +$2.18M | 0.15% | 185 |
|
2024
Q1 | – | Sell |
-7,344
| Closed | -$1.61M | – | 1783 |
|
2023
Q4 | $1.61M | Buy |
7,344
+5,927
| +418% | +$1.3M | 0.15% | 184 |
|
2023
Q3 | $320K | Buy |
+1,417
| New | +$320K | 0.03% | 739 |
|
2023
Q2 | – | Sell |
-2,195
| Closed | -$492K | – | 1743 |
|
2023
Q1 | $492K | Buy |
+2,195
| New | +$492K | 0.06% | 540 |
|
2022
Q1 | – | Sell |
-3,372
| Closed | -$729K | – | 974 |
|
2021
Q4 | $729K | Sell |
3,372
-591
| -15% | -$128K | 0.17% | 173 |
|
2021
Q3 | $731K | Buy |
3,963
+1,738
| +78% | +$321K | 0.13% | 243 |
|
2021
Q2 | $399K | Buy |
+2,225
| New | +$399K | 0.1% | 326 |
|